Latest Period
Q1 2026
Security Snapshot
Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE) Institutional Ownership
CUSIP: 922967104
13F Institutional Holders and Ownership History for Q1 2026
Institutions Reporting
79
Shares (Excl. Options)
25,900,481
Price
$63.15
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- MANE on NYSE
- Shares outstanding
- 37,567,889
- Price per share
- $106.55
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 25,900,481
- Total reported value
- $1,633,376,643
- % of total 13F portfolios
- 0.01%
- Share change
- +24,990,723
- Value change
- +$1,575,925,425
- Number of holders
- 79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- MANE - Veradermics, Inc - Common Stock, par value $0.00001 per share is tracked under CUSIP 922967104.
- 79 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Latest quarter on this page is Q1 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 79 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 922967104?
CUSIP 922967104 identifies MANE - Veradermics, Inc - Common Stock, par value $0.00001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 922967104:
Significant Owners of Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Longitude Capital Partners V, LLC | 11% | -9.2% | $320,186,462 | 4,653,873 | 0% | Patrick G. Enright | 01 May 2026 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.9% | -17% | $287,041,925 | +$215,344 | 4,172,121 | +0.08% | SUVRETTA CAPITAL MANAGEMENT, LLC | 01 May 2026 |
| SR ONE CAPITAL MANAGEMENT, LLC | 6.4% | 2,401,868 | SR One Capital Management, LLC | 05 Feb 2026 | ||||
| CITADEL ADVISORS LLC | 4.5% | $128,710,490 | 1,870,792 | Kenneth Griffin | 30 Apr 2026 | |||
| VIKING GLOBAL INVESTORS LP | 4.5% | -22% | $116,310,184 | -$31,712,534 | 1,690,555 | -21% | VIKING GLOBAL INVESTORS LP | 31 Mar 2026 |
| Seven Fleet Capital Management LP | 0.2% | $5,504,000 | 80,000 | Seven Fleet Capital Management LP | 01 May 2026 |
As of 31 Mar 2026, 79 institutional investors reported holding 25,900,481 shares of Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE). This represents 69% of the company’s total 37,567,889 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11% | 4,168,970 | 7.1% | $263,270,456 | |
| SR One Capital Management, LP | 6.4% | 2,401,868 | 17% | $151,677,964 | |
| CITADEL ADVISORS LLC | 4.9% | 1,825,672 | 0.08% | $115,291,187 | |
| FMR LLC | 4.8% | 1,792,909 | 0.01% | $113,222,208 | |
| VIKING GLOBAL INVESTORS LP | 4.5% | 1,690,555 | 0.3% | $106,758,548 | |
| Siren, L.L.C. | 4% | 1,505,374 | 2.6% | $95,064,368 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.9% | 1,100,000 | 0.11% | $69,465,000 | |
| Aberdeen Group plc | 2.8% | 1,054,660 | 0.11% | $66,601,779 | |
| JPMORGAN CHASE & CO | 2.6% | 976,166 | 0% | $59,399,700 | |
| INFINITUM ASSET MANAGEMENT, LLC | 1.9% | 731,149 | 5.8% | $46,172,059 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9% | 699,645 | 0% | 0% | $44,182,582 |
| MARSHALL WACE, LLP | 1.7% | 654,601 | 0.04% | $41,338,053 | |
| Balyasny Asset Management L.P. | 1.4% | 532,906 | 0.07% | $33,653,014 | |
| Paradigm Biocapital Advisors LP | 1.4% | 525,000 | 0.68% | $33,153,750 | |
| AMERIPRISE FINANCIAL INC | 1.4% | 514,035 | 0.01% | $32,461,444 | |
| Woodline Partners LP | 1.3% | 500,646 | 0.12% | $31,615,795 | |
| Deep Track Capital, LP | 1.3% | 500,000 | 0.65% | $31,575,000 | |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3% | 477,833 | 0.01% | $30,175,154 | |
| UBS Group AG | 0.92% | 347,075 | 0% | $21,917,786 | |
| Vivo Capital, LLC | 0.8% | 300,000 | 1.6% | $18,945,000 | |
| STIFEL FINANCIAL CORP | 0.78% | 294,117 | 0.02% | $18,573,489 | |
| BlackRock, Inc. | 0.75% | 282,611 | 0% | $17,846,885 | |
| FRANKLIN RESOURCES INC | 0.53% | 200,000 | 0% | $12,630,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.47% | 178,206 | 0% | $11,260,302 | |
| Catalio Capital Management, LP | 0.46% | 173,582 | 2.3% | $10,961,703 |
Institutional Holders of Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,900,481 | $1,633,376,643 | +$1,575,925,425 | $63.15 | 79 |